Memorial Sloan Kettering Cancer Center
New York, 10065, United States
NCT Number: NCT00717795
The purpose of this study is to learn how many lung cancer survivors will agree to a physical activity program. We also want to know if lung cancer survivors benefit from this program. This information will help us to develop our services for lung cancer survivors.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
New York, 10065, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
FOCUS GROUP ONLY:
Exclusion criteria
For Arm 1 participants in the Physical Activity intervention condition will be assessed at baseline, and postintervention Follow-up (at 12 weeks post baseline).
Participants in the control condition (Arm 2)will be assessed at baseline and 12 weeks post baseline (Follow-up). At this time, the PA intervention will be offered at no cost to the participants in the control condition. If the waitlist participant chooses to complete the PA intervention after the 12 week waitlist period, program satisfaction will be assessed after study completion.
Time frame: conclusion of the study
Time frame: conclusion of the study
Time frame: conclusion of the study
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06003335
Behavior, Cancer-related Cognitive Impairment
Hong Kong
View Trial DetailsNCT07591376
Behavior, Lung Cancer
Vejle, Denmark
View Trial DetailsNCT03724331
Behavior, Bronchial Neoplasms
Omaha, Nebraska, United States
View Trial DetailsNCT02493114
Behavior, Exercise Capacity
Genk, Belgium
View Trial Details